Blockade of mineralocorticoid receptor ameliorates glucose and lipid metabolism, steatohepatitis, and hepatic fibrosis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

T.Wada; Y.Miyashita; M.Sasaki; Y.Ishii; M.Sasahara; H.Tsuneki; T.Sasaoka

Blockade of mineralocorticoid receptor ameliorates glucose and lipid metabolism, steatohepatitis, and hepatic fibrosis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

T.Wada, Y.Miyashita, M.Sasaki, Y.Ishii, M.Sasahara, H.Tsuneki, T.Sasaoka

Research output: Contribution to conference › Presentation

Original language	Japanese
State	Published - 2010
Externally published	Yes
Event	The 9th JSH Single Topic Conference "NASH 2010"(日本肝臓病学会主催) - Duration: 2010/01/01 → …

Conference

Conference	The 9th JSH Single Topic Conference "NASH 2010"(日本肝臓病学会主催)
Period	2010/01/01 → …

Cite this

T.Wada, Y.Miyashita, M.Sasaki, Y.Ishii, M.Sasahara, H.Tsuneki, & T.Sasaoka (2010). Blockade of mineralocorticoid receptor ameliorates glucose and lipid metabolism, steatohepatitis, and hepatic fibrosis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.. The 9th JSH Single Topic Conference "NASH 2010"(日本肝臓病学会主催).

@conference{8c0318af221f4ba38e3a7da8c3d0c427,

title = "Blockade of mineralocorticoid receptor ameliorates glucose and lipid metabolism, steatohepatitis, and hepatic fibrosis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.",

author = "T.Wada and Y.Miyashita and M.Sasaki and Y.Ishii and M.Sasahara and H.Tsuneki and T.Sasaoka",

year = "2010",

language = "日本",

note = "The 9th JSH Single Topic Conference "NASH 2010"(日本肝臓病学会主催) ; Conference date: 01-01-2010",

}

T.Wada, Y.Miyashita, M.Sasaki, Y.Ishii, M.Sasahara, H.Tsuneki & T.Sasaoka 2010, 'Blockade of mineralocorticoid receptor ameliorates glucose and lipid metabolism, steatohepatitis, and hepatic fibrosis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.', The 9th JSH Single Topic Conference "NASH 2010"(日本肝臓病学会主催), 2010/01/01.

Blockade of mineralocorticoid receptor ameliorates glucose and lipid metabolism, steatohepatitis, and hepatic fibrosis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice. / T.Wada; Y.Miyashita; M.Sasaki et al.
2010. The 9th JSH Single Topic Conference "NASH 2010"(日本肝臓病学会主催).

Research output: Contribution to conference › Presentation

TY - CONF

T1 - Blockade of mineralocorticoid receptor ameliorates glucose and lipid metabolism, steatohepatitis, and hepatic fibrosis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

AU - T.Wada,

AU - Y.Miyashita,

AU - M.Sasaki,

AU - Y.Ishii,

AU - M.Sasahara,

AU - H.Tsuneki,

AU - T.Sasaoka,

PY - 2010

Y1 - 2010

M3 - 学会発表

T2 - The 9th JSH Single Topic Conference "NASH 2010"(日本肝臓病学会主催)

Y2 - 1 January 2010

ER -

T.Wada, Y.Miyashita, M.Sasaki, Y.Ishii, M.Sasahara, H.Tsuneki et al.. Blockade of mineralocorticoid receptor ameliorates glucose and lipid metabolism, steatohepatitis, and hepatic fibrosis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.. 2010. The 9th JSH Single Topic Conference "NASH 2010"(日本肝臓病学会主催).